| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.02 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |